Atlas Trials

A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

Clinical trial NCT04486482 · COMPLETED

Trial details

NCT number
NCT04486482
Sponsor
Kaleido Biosciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Mild-to-Moderate COVID-19
Start date
2021-01-12
Primary completion
2021-03-30
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.